Author Question: What is the 5-year survival rate for patients with untreated idiopathic pulmonary artery ... (Read 22 times)

mydiamond

  • Hero Member
  • *****
  • Posts: 804
What is the 5-year survival rate for patients with untreated idiopathic pulmonary artery hyperten-sion (IPAH)?
 
  a. 33
  b. 44
  c. 55
  d. 66

Question 2

What is the most common pulmonary function abnormality found in patients with idiopathic pulmonary artery hypertension (IPAH)?
 
  a. Reduced diffusing capacity of the lungs (DLCO)
  b. Reduced forced vital capacity (FVC)
  c. Reduced forced expiratory flow (FEF25 to 75)
  d. Reduced lung compliance (CL)



aloop

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

ANS: A
IPAH can be life threatening and carries a poor prognosis. Without therapy, only 33 of patients are alive 5 years after the onset of the disorder.

Answer to Question 2

ANS: A
Pulmonary function tests are useful to rule out the presence of significant restrictive or obstruc-tive airway disease. The most common abnormality at pulmonary function testing of patients with IPAH is a low carbon monoxide diffusing capacity (DLCO).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

For a complete list of videos, visit our video library